. 2019 May 13;5(2):147–154. doi: 10.5114/ceh.2019.85074
Copyright: © 2019 Clinical and Experimental Hepatology
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Fig. 1.
Visfatin serum concentrations in CHC patients and control group